Clinical Trial Update: Exploratory Study of Tipranavir and Ritonavir in Multiple Protease Inhibitor-experienced HIV Patients [Phase 2]

View source ↗

Summary

This Phase 2 exploratory trial studied tipranavir boosted with ritonavir in HIV-infected patients who have experienced protease inhibitors. The study has comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Ritonavir (Ritonavir)
• Tipranavir (tipranavir)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: HIV Infections | Phase 2 | Status: COMPLETED